[ XXXX in selected heamatology departments in the Czech Republic and Slovakia - microbiological results of the CAN CELL project].

@entity1 @entity375 @entity2379 @entity5 @entity7408 @entity7409 @entity5132 @entity281 @entity5626 @entity3 @entity6251 @entity8201
BACKGROUND: The aim of our study was to analyze the spectrum and characteristic of @entity3 in selected haematological departments in the Czech and Slovak Republics, and to compare @entity6251 ( @entity6251 ) of some antifungal agents for isolates obtained. MATERIAL AND METHODS: Between 1 March 2009 and 31 October 2010, Candida strains from clinically important material obtained from @entity1 with haematological @entity5 were collected. Each isolate was biochemically identified and tested for in vitro susceptibility to three known @entity5626 and @entity2379 and selected azoles using the E-test. Relevant clinical data were collected. RESULTS: The study included 63 isolates from 61 @entity1 . The most frequently isolated species were @entity5132 and @entity7408 (28 % and 19 %, respectively). However, after exclusion of isolates from bronchoalveolar lavage fluid, the percentage changed in favour of @entity5132 and @entity7409 (25 % and 17 respectively). The @entity6251 data showed a high susceptibility of @entity375 to @entity5626 and @entity2379 . Ten (16 %) strains were cross-resistant to @entity8201 (mostly @entity7408 ). CONCLUSION: @entity3 is not frequent @entity281 in @entity1 with haematological @entity5 in the Czech Republic and Slovakia. Moreover, the spectrum of pathogens was similar to that described in recent international studies. However, identification of susceptible and resistant strains according to @entity6251 could be beneficial for choice of antifungal treatment.
